Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) — The “Automated Compounding Devices Market by Type, Application, End User, Distribution Channel, Software Type, Workflow Type – Global Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
The Automated Compounding Devices Market grew from USD 2.56 billion in 2024 to USD 2.84 billion in 2025. It is expected to continue growing at a CAGR of 10.59%, reaching USD 4.69 billion by 2030.
Automated compounding devices are advancing the future of medication preparation, driving greater safety, efficiency, and adaptability. Strategic insights from this report support leaders in making informed technology investments that align with evolving clinical and operational needs.
Automated compounding devices are transforming pharmaceutical operations by streamlining medication preparation processes, maximizing safety, and ensuring precision. Senior decision-makers seeking to optimize healthcare delivery must understand the factors shaping this market’s rapid evolution and the technological trends driving future growth.
Underscored by rising demand for personalized therapies, enhanced regulatory oversight, and operational innovation, automated compounding solutions are now essential for hospitals, pharmacies, and healthcare providers aiming for greater quality and efficiency in medication delivery. Advances in robotics, software integration, and real-time monitoring are setting new benchmarks for reliability and compliance while expanding global adoption across diverse healthcare settings.
Scope & Segmentation
- Device Types: Peristaltic, piston-driven, and volumetric mechanisms each cater to differing accuracy and integration needs within healthcare operations.
- Applications: Supports analgesia, general oncology, targeted therapy, parenteral nutrition (for both central and peripheral venous delivery), covering a comprehensive range of clinical specialties.
- End Users: Solutions tailored for compounding pharmacies, home healthcare, large and small hospital pharmacies, and retail pharmacies to suit a variety of workflow and staffing models.
- Distribution Channels: Direct sales, distribution via national and regional partners, and online platforms each play a critical role in procurement and market reach.
- Software Types: Integrated software supports seamless electronic health record connections; standalone applications offer plug-and-play flexibility.
- Workflow Types: Batch and continuous modes address high-volume and just-in-time compounding requirements accordingly.
- Regional Coverage: Analysis spans the Americas (including the United States and major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (across 21 countries), and Asia-Pacific (including China, India, Japan, Australia, South Korea, and more).
Key Takeaways for Senior Decision-Makers
- Compounding automation is helping minimize manual errors, supporting regulatory compliance, and enhancing the consistency of medication preparations in clinical and pharmacy environments.
- Integration of digital technologies-such as cloud-based analytics and real-time feedback loops-improves operational visibility, enables predictive maintenance, and reduces device downtime.
- The adoption of modular, standardized device architectures accelerates deployment and facilitates cost-efficient scaling across international operations.
- Market leaders are shifting from transactional models to service-oriented approaches, leveraging data analytics to deliver outcome-based engagements and added value for clients.
- Continuous investments in software innovation and remote diagnostics are enabling rapid adaptation to changing therapy protocols and expanding therapy libraries.
Key Companies
- Baxter International Inc.
- Fresenius Kabi AG
- B. Braun Melsungen AG
- ICU Medical, Inc.
- Omnicell, Inc.
- Ivenix, Inc.
- Qcore Medical, Inc.
- Telstar S.A.
- Swisslog AG
- Capsa Healthcare, Inc.
Key Attributes:
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Compounding Devices Market, by Type
8.1. Introduction
8.2. Peristaltic
8.3. Piston Driven
8.4. Volumetric
9. Automated Compounding Devices Market, by Application
9.1. Introduction
9.2. Analgesia
9.3. Chemotherapy
9.3.1. General Oncology
9.3.2. Targeted Therapy
9.4. Parenteral Nutrition
9.4.1. Central Venous
9.4.2. Peripheral Venous
10. Automated Compounding Devices Market, by End User
10.1. Introduction
10.2. Compounding Pharmacy
10.3. Home Healthcare
10.4. Hospital Pharmacy
10.4.1. Large Hospital
10.4.2. Small Hospital
10.5. Retail Pharmacy
11. Automated Compounding Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.3.1. National Distributors
11.3.2. Regional Distributors
11.4. Online Sales
12. Automated Compounding Devices Market, by Software Type
12.1. Introduction
12.2. Integrated
12.3. Standalone
13. Automated Compounding Devices Market, by Workflow Type
13.1. Introduction
13.2. Batch
13.3. Continuous
For more information about this report visit https://www.researchandmarkets.com/r/5l2f12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
